Subcutaneous Drug Delivery Market Industry Growth, Size, Share, and Forecast 2018-2026

Combination products, particularly injectable drug delivery systems such as prefilled syringes are largely being adopted, with increasing number of injectable biological drugs, by healthcare professionals, owing to higher convenience.

According to the study named Growth & Benefits of Pre-Filled Syringes by Fisher Clinical Service, 2014, around 13 biotechnology products were available commercially in the market in 1989, which increased to 210 in 2012. As per Fisher Clinical Service, in 2013, the prefilled syringes segment was expected to account for a quarter of the total injectables drug delivery systems, which included around 35 of the 100 top-selling drugs, which were to be incorporated in the form of injection.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/2933

In December 2016, Becton, Dickinson and Company announced the launch of BD Neopak 2.25 mL prefillable glass syringe, which is developed for biopharmaceutical manufacturers focused on manufacturing of sensitive biologic drugs for the treatment of chronic diseases such as rheumatoid arthritis, psoriasis, lupus, and severe asthma. The syringe offers higher volume subcutaneous injections, thereby helping to improve safety and convenience for patients.

Small companies are focused on development of novel epinephrine auto injectors, which offer thermal stability. Currently available products work optimally at specific temperatures, thereby providing a growth opportunity for manufacturers in the global subcutaneous drug delivery market. For instance, Windgap Medical is focused on developing a portable device that would mix a dry formulation of the drug into solution, thus providing temperature stability and a longer shelf-life of medication, for patients suffering from anaphylaxis due to an acute allergy attack.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2933

Detailed Segmentation:

By Usability:

Disposable

Reusable

By Disease Indication:

Auto-immune Disorders

Neurological Disorders

Oncology Disorders

Hormonal Disorders

Allergy & Infectious Disorders

Ophthalmic Disorders

Others

By Delivery Type:

Prefilled Syringe

Injector

Prefilled Pen

Vial (Syringe)

Pump and Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Companies operating in the global subcutaneous drug delivery market include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.

Browse the Full Report Here: https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com